Quick Answer
Zenas BioPharma, Inc. reported Total Assets of $383.64 million for fiscal year 2025.
Zenas BioPharma, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $383.64M | +3.7% |
| 2024 | $369.97M | +442.6% |
| 2023 | $68.18M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $322.02M | -20.2% | +9.9% |
| June 30, 2025 | $293.08M | — | -12.2% |
| March 31, 2025 | $333.77M | — | -9.8% |
| December 31, 2024 | $369.97M | +442.6% | -8.3% |
| September 30, 2024 | $403.43M | — | +491.7% |
| December 31, 2023 | $68.18M | — | — |
- Zenas BioPharma, Inc. showed an increase of +3.7% in Total Assets compared to the prior fiscal year.
- Over the 2023–2025 period, Zenas BioPharma, Inc.’s total assets has grown by 462.7% (from $68.18 million to $383.64 million).
- The most recent figure is from Zenas BioPharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: